identified distinct signatures of neoantigen‐reactive CD8+ and CD4+ TILs, which show tumor‐specific expansion but exhibit dysfunctional phenotypes, differing from blood‐derived bystanders and regulatory TILs.[86] Similarly, Oliveira et al. This evidence concerns the gene CD8A and neoplasm.